Linzopedia Dry Syrup

Composition:  Each 5ml contains. 100mg of Linezolid

Flavour: Orange Flavour

Formulation: Dry Syrup for Oral Administration

Therapy/Class: Antibacterial Agent / Oxazolidinone Class


Spectrum of Coverage:

  • Aerobic & facultative Gram-positive microorganisms

> Enterococcus faecium (vancomycin-resistant strains only)

> Staphylococcus aureus (including methicillin-resistant strains)

> Streptococcus agalactiae

> Streptococcus pneumoniae (including multi-drug resistant isolates [MDRSP]

> Streptococcus pyogen

  • Aerobic & facultative Gram-negative microorganisms

> Pasteurella multocida


Spectrum of Coverage:

> Inhibits bacterial protein synthesis

> Bacteriostatic against Enterococci & Staphylococci Strains  whereas, bactericidal against Streptococci & majority of bacterial strain

> Binds to 23S ribosomal RNA of the 50S subunit & prevents the formation of a functional 70S initiation complex which is an essential component of the bacterial translation process.


> Vancomycin-Resistant Enterococcus faecium infections

> Nosocomial pneumonia

> Complicated skin & skin structure infections, including diabetic foot infections, without concomitant osteomyelitis

> Uncomplicated skin & skin structure infections

> Community-acquired pneumonia


Dosage & Administration:

Infection*Pediatric Patients
(Birth through 11 Years of Age)
Adolescents & Adults
(12 Years & Older)
Recommended Duration of Treatment (Consecutive Days)
Nosocomial pneumonia10 mg/kg every 8 hours600 mg 12 hours10 to 14
Community-acquired pneumonia, including concurrent bacteremia 
Complicated skin and skin structure
Vancomycin-resistant Enterococcus faecium infections, including concurrent bacteremia 10 mg/kg every 8 hours600 mg every 12 hours14 to 28
Uncomplicated skin and skin structure infections 

<5 yrs: 10 mg/kg every 8 hours 

5-11 yrs: 10 mg/kg every 12 hours

Adolescents: 600 mg every 12 hours Adults: 400 mg every 12 hours 10 to 14


> 30 ml Oral Dry Syrup is available in Dry Powdered form with Sterile Water.


> Fine MJ, Auble TE, Yealy DM, et al. A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia. The New England Journal of Medicine. 1997;336 (4):243-250.


There are no reviews yet.

Be the first to review “Linzopedia Dry Syrup”

Your email address will not be published. Required fields are marked *

error: Content is protected !!